comprehensive -WSS

comprehensive

author：comprehensive 2025-10-03 00:40:18 - browse：24

House Judiciary Chairman Jerrold Nadler (D-NY) listens as Rep. Judy Chu (D-CA) speaks during a news conference. — Reps. Jerry Nadler (D-N.Y.) and Judy Chu (D-Calif.) Joshua Roberts/Getty Images

House Democrats are raising concerns with the Biden administration that Medicare Advantage plans need better oversight, citing recent STAT investigations that found insurance companies are using artificial intelligence and algorithmic software to deny care even when people still need it.

On Friday, Rep. Judy Chu of California and Rep. Jerry Nadler of New York spearheaded a letter to the Centers for Medicare and Medicaid Services asking the agency to step up its oversight of Medicare Advantage insurers. Thirty other House Democrats also signed onto the letter.

STAT previously reported Medicare Advantage insurers are using proprietary algorithms and AI to initiate payment denials, but that technology does not fully account for someone’s particular care needs. As a result, many frail patients have been kicked out of nursing homes, faced the prospect of draining their savings, or slogged through a long appeals process to get care they and their clinical teams think they need.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Chronically ill young patients struggle to find fertility info

WSS

GSK Flovent asthma inhalers replaced by authorized generics

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

Innovation in antibiotics is ailing. 'Brain drain' may kill it

The biotech scorecard for Q1: 17 stock

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

Kaiser's Risant Health gobbled up Geisinger. Who is next?

entertainment

comprehensive

hotspot

Tori Bowie and the unacceptable rates of Black maternal death

Why psychiatrists like me stop taking insurance

DIEP, the 'gold standard' of breast reconstruction, is under threat

New weight loss drugs work. But how can they best be used?

Affirmative action in medical school literally saved lives

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

Drug repurposing or repositioning? The language matters

3 trends to watch in health tech's hiring outlook for 2024

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Ionis drug prevents swelling attacks due to hereditary angioedema

leisure time

GSK Flovent asthma inhalers replaced by authorized generics

At ASCO, AstraZeneca reports strong data for breast cancer drug

New weight loss drugs work. But how can they best be used?

ASCO: AstraZeneca says CAR

FDA's Pazdur wants cancer trials to range beyond China alone

At ASCO, AstraZeneca reports strong data for breast cancer drug

hotspot

knowledge

entertainment

hotspot